The Thomistic Institute

The Challenge and Opportunity of Genome Editing | Dr. William Hurlbut

Dec 12, 2020
Dr. William Hurlbut, a genome editing expert, discusses the transformative potential of CRISPR-Cas9 technology in genetic modification, the use of CRISPR for treating genetic diseases like sickle cell anemia, the challenges in intervening in genetic conditions, the historical ties of medicine with eugenics, and the ethical dilemmas surrounding human genome editing, emphasizing the need for cautious approach and open discussions on the moral implications.
Ask episode
Chapters
Transcript
Episode notes